跳至主要内容
临床试验/CTRI/2019/03/017955
CTRI/2019/03/017955尚未招募不适用

Comparison of effectiveness of trihexyphenidyl and levodopa on motor symptoms in Parkinson’s disease

Department of Neurology1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2019年3月15日最近更新:

试验速览

阶段
不适用
状态
尚未招募
入组人数
30
试验地点
1
主要终点
Decrease in UPDRS motor scores after the treatment

研究概览

简要总结

There are very few studies assessingthe effectiveness of trihexyphenidyl inimproving motor symptoms in PD.Studies comparing effectiveness of trihexyphenidyl and levodopa in PDpatients are also very rare.We plan to evaluate 30 patients with Parkinson’s disease and objectively assess the response of their motor features to levodopa and trihexyphenidyl respectively.

研究设计

研究类型
Interventional
分配方式
Not Applicable
盲法
Not Applicable

入排标准

年龄范围
30.00 Year(s) 至 65.00 Year(s)(—)
性别
All

入选标准

  • Parkinson’s disease patients (fulfilling MDS clinical diagnostic criteria for PD) (who are currently taking or had taken trihexyphenidyl in the past).

排除标准

  • 1.Patients with cognitive and behavioral disturbances.
  • 2.Patients with history of urinary disturbances and benign hyperplasia of prostate.
  • 3.Patients with angle closure glaucoma.
  • 4.Patients with h/o cardiac illness 5.Patients with h/o postural hypotension.
  • 6.Lack of consent.

结局指标

主要结局

Decrease in UPDRS motor scores after the treatment

时间窗: Baseline, after 1 hour of levodopa tablets, after 48 hours, after 30 minutes, after 60 minutes, after 90 minutes, after 120 minutes

次要结局

未报告次要终点

研究者

申办方类型
Research institution and hospital

研究点 (1)

Loading locations...

相似试验